Sort
10,766 grants matching “checkpoint inhibitor”
Molecular Imaging and Theranostics of Cancer
$962,412Zaver M Bhujwalla · Johns Hopkins University · R35 · FY2023 · CA
Study of the Roles of SDF1 and CXCR4 in Hematopoiesis
$962,192Giovanna Tosato · Division Of Basic Sciences - Nci · ZIA · FY2024 · CA
Vaccine and immunotherapy strategies for cancer and viruses causing cancer
$960,045Jay A Berzofsky · Division Of Clinical Sciences - Nci · ZIA · FY2022 · CA
Genome instability in cancer: telomeres and DNA repair
$957,507Titia De Lange · Rockefeller University · R35 · FY2024 · CA
Understanding and targeting the DNA replication stress in cancer cells
$957,501Lee Zou · Duke University · R35 · FY2025 · CA
DNA Repair, Cell Cycle Checkpoints and Apoptosis as Targets for Anticancer Drugs
$957,460Yves Pommier · Division Of Basic Sciences - Nci · ZIA · FY2013 · CA
Regulation of PDAC metabolism and immunity by collagen and its cleavage products
$955,015Michael Karin · University Of California, San Diego · U01 · FY2023 · CA
Molecular Pathogenesis of Neoplasia
$953,971John Heiss · National Institute Of Neurological Disorders And Stroke · ZIA · FY2023 · NS
Muscle Disease Unit
$953,621Andrew Mammen · National Institute Of Arthritis And Musculoskeletal And Skin Diseases · ZIA · FY2015 · AR
Molecular Imaging and Theranostics of Cancer
$952,718Zaver M Bhujwalla · Johns Hopkins University · R35 · FY2019 · CA
Exploring DNA damage response pathways as targets for cancer therapy
$952,560Junjie Chen · University Of Tx Md Anderson Can Ctr · R35 · FY2023 · CA
Immunology And Pathology Of Acute and Chronic Murine Leukemia Virus Infections
$952,491Kim Hasenkrug · National Institute Of Allergy And Infectious Diseases · ZIA · FY2022 · AI
Initiation Of DNA Replication In Mammalian Chromosomes
$951,810Melvin Depamphilis · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2014 · HD
Gene Expression At The Beginning Of Mammalian Development
$951,810Melvin Depamphilis · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2014 · HD
Systems genetics analysis of tumor evolution in the mouse
$951,000Allan Balmain · University Of California, San Francisco · R35 · FY2020 · CA
Systems genetics analysis of tumor evolution in the mouse
$951,000Allan Balmain · University Of California, San Francisco · R35 · FY2021 · CA
Systems genetics analysis of tumor evolution in the mouse
$951,000Allan Balmain · University Of California, San Francisco · R35 · FY2018 · CA
Clinical evaluation of combination oncolytic viro-immunotherapy for solid tumors
$950,045Rosa Maria Diaz · Vyriad, Inc. · R44 · FY2019 · CA
Determinants of response to cancer immunotherapy
$949,572Lawrence Fong · University Of California, San Francisco · R35 · FY2022 · CA
Determinants of response to cancer immunotherapy
$949,572Lawrence Fong · University Of California, San Francisco · R35 · FY2023 · CA
Oncolytic Polovirus, Immunotoxin, and Checkpoint Inhibitor Therapy of Gliomas
$948,679Darell D Bigner · Duke University · R35 · FY2015 · CA
Combining receptor-targeted alpha particle therapy and immunotherapy to achieve complete responses in metastatic melanoma
$948,099Michael King Schultz · Viewpoint Molecular Targeting, Inc. · R44 · FY2023 · CA
Administrative Core
$947,067Jun Yan · University Of Louisville · P20 · FY2024 · GM
Center for Cancer Immunology and Immunotherapy (CCII).
$947,067Jun Yan · University Of Louisville · P20 · FY2024 · GM
Understanding and targeting the DNA replication stress in cancer cells
$946,265Lee Zou · Duke University · R35 · FY2023 · CA